WO2017011552A1
(en)
|
2015-07-13 |
2017-01-19 |
Enanta Pharmaceuticals, Inc. |
Hepatitis b antiviral agents
|
CA3017020C
(en)
|
2016-03-07 |
2024-01-16 |
Enanta Pharmaceuticals, Inc. |
Hepatitis b antiviral agents
|
WO2017202704A1
(en)
*
|
2016-05-23 |
2017-11-30 |
F. Hoffmann-La Roche Ag |
Benzazepine dicarboxamide compounds with tertiary amide function
|
EP3464274B1
(en)
|
2016-05-23 |
2020-05-27 |
H. Hoffnabb-La Roche Ag |
Benzazepine dicarboxamide compounds with secondary amide function
|
BR102017010009A2
(pt)
|
2016-05-27 |
2017-12-12 |
Gilead Sciences, Inc. |
Compounds for the treatment of hepatitis b virus infection
|
WO2017214395A1
(en)
|
2016-06-10 |
2017-12-14 |
Enanta Pharmaceuticals, Inc. |
Hepatitis b antiviral agents
|
JP7012668B2
(ja)
|
2016-06-12 |
2022-02-14 |
エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト |
ジヒドロピリミジニルベンズアゼピンジカルボキサミド化合物
|
CN109311880B
(zh)
*
|
2016-06-29 |
2021-09-03 |
豪夫迈·罗氏有限公司 |
用于治疗和预防乙型肝炎病毒感染的新的四氢吡啶并嘧啶类化合物
|
WO2018022282A1
(en)
|
2016-07-29 |
2018-02-01 |
Newave Pharmaceutical Inc. |
Novel therapeutic agents for the treatment of hbv infection
|
IL265921B2
(en)
|
2016-10-14 |
2024-05-01 |
Prec Biosciences Inc |
Transgenic meganonucleases specific for recognition sequences in the hepatitis B virus genome
|
CN116751200A
(zh)
|
2016-11-07 |
2023-09-15 |
爱彼特生物制药公司 |
含有取代的吡啶酮的三环化合物以及使用其的方法
|
JOP20180008A1
(ar)
|
2017-02-02 |
2019-01-30 |
Gilead Sciences Inc |
مركبات لعلاج إصابة بعدوى فيروس الالتهاب الكبدي b
|
AU2018232071B2
(en)
|
2017-03-09 |
2021-07-08 |
Fujian Akeylink Biotechnology Co., Ltd. |
Hepatitis B virus surface antigen inhibitor
|
MA49014A
(fr)
|
2017-03-21 |
2020-02-05 |
Arbutus Biopharma Corp |
Dihydroindène-4-carboxamides substitués, leurs analogues et procédés d'utilisation correspondant
|
CN110475775B
(zh)
|
2017-03-31 |
2023-05-09 |
富士胶片株式会社 |
4-吡啶酮化合物或其盐、包含4-吡啶酮化合物的药物组合物及剂
|
AU2018271643B2
(en)
*
|
2017-05-22 |
2022-06-02 |
Fujian Akeylink Biotechnology Co., Ltd. |
Hepatitis B virus surface antigen inhibitor
|
CN108884107B
(zh)
*
|
2017-05-22 |
2019-08-09 |
福建广生堂药业股份有限公司 |
乙型肝炎病毒表面抗原抑制剂
|
CN110066278B
(zh)
*
|
2017-06-01 |
2021-06-08 |
广东东阳光药业有限公司 |
稠合三环类化合物及其在药物中的应用
|
UY37861A
(es)
|
2017-08-28 |
2019-03-29 |
Enanta Pharm Inc |
Agentes antivirales contra la hepatitis b
|
AR113826A1
(es)
|
2017-11-02 |
2020-06-17 |
Aicuris Gmbh & Co Kg |
Indol-2-carboxamidas sustituidas con amino-tiazol activas contra el virus de la hepatitis b (vhb)
|
CA3081399A1
(en)
|
2017-11-02 |
2019-05-09 |
Aicuris Gmbh & Co. Kg |
Novel, highly active pyrazolo-piperidine substituted indole-2-carboxamides active against the hepatitis b virus (hbv)
|
GB201720163D0
(en)
*
|
2017-12-04 |
2018-01-17 |
Galapagos Nv |
Novel compounds and pharmaceutical compositions thereof for the treatment of hepatitis B
|
WO2019113175A1
(en)
|
2017-12-06 |
2019-06-13 |
Enanta Pharmaceuticals, Inc. |
Hepatitis b antiviral agents
|
TW201927789A
(zh)
|
2017-12-06 |
2019-07-16 |
美商因那塔製藥公司 |
B型肝炎抗病毒試劑
|
CN111511754B
(zh)
|
2017-12-20 |
2023-09-12 |
捷克共和国有机化学与生物化学研究所 |
活化sting转接蛋白的具有膦酸酯键的2’3’环状二核苷酸
|
EP3728283B1
(en)
|
2017-12-20 |
2023-11-22 |
Institute of Organic Chemistry and Biochemistry ASCR, V.V.I. |
3'3' cyclic dinucleotides with phosphonate bond activating the sting adaptor protein
|
US11058678B2
(en)
|
2018-01-22 |
2021-07-13 |
Enanta Pharmaceuticals, Inc. |
Substituted heterocycles as antiviral agents
|
EP3759109B1
(en)
|
2018-02-26 |
2023-08-30 |
Gilead Sciences, Inc. |
Substituted pyrrolizine compounds as hbv replication inhibitors
|
TWI801517B
(zh)
*
|
2018-03-12 |
2023-05-11 |
加拿大商愛彼特生物製藥公司 |
經取代的2-吡啶酮三環化合物、其類似物及其使用方法
|
WO2019191166A1
(en)
|
2018-03-29 |
2019-10-03 |
Enanta Pharmaceuticals, Inc. |
Hepatitis b antiviral agents
|
EP3774883A1
(en)
|
2018-04-05 |
2021-02-17 |
Gilead Sciences, Inc. |
Antibodies and fragments thereof that bind hepatitis b virus protein x
|
TWI818007B
(zh)
|
2018-04-06 |
2023-10-11 |
捷克科學院有機化學與生物化學研究所 |
2'3'-環二核苷酸
|
TW202005654A
(zh)
|
2018-04-06 |
2020-02-01 |
捷克科學院有機化學與生物化學研究所 |
2,2,─環二核苷酸
|
KR20200140867A
(ko)
|
2018-04-06 |
2020-12-16 |
인스티튜트 오브 오가닉 케미스트리 앤드 바이오케미스트리 에이에스 씨알 브이.브이.아이. |
3'3'-사이클릭 다이뉴클레오티드
|
US11142750B2
(en)
|
2018-04-12 |
2021-10-12 |
Precision Biosciences, Inc. |
Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
|
TW202010499A
(zh)
|
2018-04-12 |
2020-03-16 |
加拿大商愛彼特生物製藥公司 |
經取代的吡啶酮之三環化合物的製備方法
|
TW202014193A
(zh)
|
2018-05-03 |
2020-04-16 |
捷克科學院有機化學與生物化學研究所 |
包含碳環核苷酸之2’3’-環二核苷酸
|
WO2020028097A1
(en)
|
2018-08-01 |
2020-02-06 |
Gilead Sciences, Inc. |
Solid forms of (r)-11-(methoxymethyl)-12-(3-methoxypropoxy)-3,3-dimethyl-8-0x0-2,3,8,13b-tetrahydro-1h-pyrido[2,1-a]pyrrolo[1,2-c] phthalazine-7-c arboxylic acid
|
CA3111792A1
(en)
*
|
2018-09-05 |
2020-03-12 |
Children's Medical Center Corporation |
Papd5 inhibitors and methods of use thereof
|
BR112021005091A2
(pt)
|
2018-09-21 |
2021-06-08 |
Enanta Pharmaceuticals, Inc. |
heterociclos funcionalizados como agentes antivirais
|
KR20210069680A
(ko)
|
2018-09-30 |
2021-06-11 |
선샤인 레이크 파르마 컴퍼니 리미티드 |
융합된 사환형 화합물 및 약물에서의 이의 용도
|
TWI721623B
(zh)
|
2018-10-31 |
2021-03-11 |
美商基利科學股份有限公司 |
經取代之6-氮雜苯并咪唑化合物
|
TWI721624B
(zh)
|
2018-10-31 |
2021-03-11 |
美商基利科學股份有限公司 |
經取代之6-氮雜苯并咪唑化合物
|
AR116946A1
(es)
|
2018-11-02 |
2021-06-30 |
Aicuris Gmbh & Co Kg |
Derivados de urea 6,7-dihidro-4h-pirazolo[4,3-c]piridinas activas contra el virus de la hepatitis b (vhb)
|
AR117188A1
(es)
|
2018-11-02 |
2021-07-21 |
Aicuris Gmbh & Co Kg |
Derivados de urea 6,7-dihidro-4h-pirazolo[1,5-a]pirazinas activas contra el virus de la hepatitis b (vhb)
|
UY38434A
(es)
|
2018-11-02 |
2020-05-29 |
Aicuris Gmbh & Co Kg |
Nuevas 6,7-dihidro-4h-pirazolo[1,5-a]pirazin indol-2-carboxamidas activas contra el virus de la hepatitis b (hbv)
|
WO2020089460A1
(en)
|
2018-11-02 |
2020-05-07 |
Aicuris Gmbh & Co. Kg |
Novel urea 6,7-dihydro-4h-thiazolo[5,4-c]pyridines active against the hepatitis b virus (hbv)
|
AR116948A1
(es)
|
2018-11-02 |
2021-06-30 |
Aicuris Gmbh & Co Kg |
Derivados de urea 6,7-dihidro-4h-pirazolo[1,5-a]pirazinas activas contra el virus de la hepatitis b (vhb)
|
UY38436A
(es)
|
2018-11-02 |
2020-05-29 |
Aicuris Gmbh & Co Kg |
Nuevas 6,7-dihidro-4h-pirazolo[1,5-a] pirazinindol-2-carboxamidas activas contra el virus de la hepatitis b (vhb)
|
EP3883570A4
(en)
|
2018-11-21 |
2022-07-13 |
Enanta Pharmaceuticals, Inc. |
FUNCTIONALIZED HETEROCYCLES AS ANTIVIRAL AGENTS
|
CA3120532C
(en)
*
|
2018-11-22 |
2023-09-26 |
Fujian Cosunter Pharmaceutical Co., Ltd. |
Crystal form of hepatitis b surface antigen inhibitor
|
TWI827760B
(zh)
|
2018-12-12 |
2024-01-01 |
加拿大商愛彼特生物製藥公司 |
經取代之芳基甲基脲類及雜芳基甲基脲類、其類似物及其使用方法
|
DK3934757T3
(da)
|
2019-03-07 |
2023-04-17 |
Inst Of Organic Chemistry And Biochemistry Ascr V V I |
2'3'-cykliske dinukleotider og prodrugs deraf
|
US11766447B2
(en)
|
2019-03-07 |
2023-09-26 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3′3′-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide as sting modulator
|
WO2020178770A1
(en)
|
2019-03-07 |
2020-09-10 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3'3'-cyclic dinucleotides and prodrugs thereof
|
TWI751517B
(zh)
|
2019-04-17 |
2022-01-01 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
TWI751516B
(zh)
|
2019-04-17 |
2022-01-01 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
SG11202111493WA
(en)
|
2019-04-30 |
2021-11-29 |
Aicuris Gmbh & Co Kg |
Novel oxalyl piperazines active against the hepatitis b virus (hbv)
|
US20220227789A1
(en)
|
2019-04-30 |
2022-07-21 |
Aicuris Gmbh & Co. Kg |
Novel indolizine-2-carboxamides active against the hepatitis b virus (hbv)
|
EP3962912A1
(en)
|
2019-04-30 |
2022-03-09 |
AiCuris GmbH & Co. KG |
Novel phenyl and pyridyl ureas active against the hepatitis b virus (hbv)
|
SG11202111236UA
(en)
|
2019-04-30 |
2021-11-29 |
Aicuris Gmbh & Co Kg |
Novel indole-2-carboxamides active against the hepatitis b virus (hbv)
|
TWI826690B
(zh)
|
2019-05-23 |
2023-12-21 |
美商基利科學股份有限公司 |
經取代之烯吲哚酮化物及其用途
|
WO2020247444A1
(en)
|
2019-06-03 |
2020-12-10 |
Enanta Pharmaceuticals, Inc, |
Hepatitis b antiviral agents
|
US11472808B2
(en)
|
2019-06-04 |
2022-10-18 |
Enanta Pharmaceuticals, Inc. |
Substituted pyrrolo[1,2-c]pyrimidines as hepatitis B antiviral agents
|
WO2020247561A1
(en)
|
2019-06-04 |
2020-12-10 |
Enanta Pharmaceuticals, Inc, |
Hepatitis b antiviral agents
|
MX2021015452A
(es)
|
2019-06-25 |
2022-02-11 |
Gilead Sciences Inc |
Proteinas de fusion flt3l-fc y metodos de uso.
|
WO2021007488A1
(en)
|
2019-07-11 |
2021-01-14 |
Enanta Pharmaceuticals, Inc. |
Substituted heterocycles as antiviral agents
|
JP7433415B2
(ja)
*
|
2019-08-15 |
2024-02-19 |
福建▲広▼生中霖生物科技有限公司 |
オキサゼピン系化合物の調製方法
|
US20220296619A1
(en)
|
2019-08-19 |
2022-09-22 |
Gilead Sciences, Inc. |
Pharmaceutical formulations of tenofovir alafenamide
|
US11236108B2
(en)
|
2019-09-17 |
2022-02-01 |
Enanta Pharmaceuticals, Inc. |
Functionalized heterocycles as antiviral agents
|
WO2021067181A1
(en)
|
2019-09-30 |
2021-04-08 |
Gilead Sciences, Inc. |
Hbv vaccines and methods treating hbv
|
CN116057068A
(zh)
|
2019-12-06 |
2023-05-02 |
精密生物科学公司 |
对乙型肝炎病毒基因组中的识别序列具有特异性的优化的工程化大范围核酸酶
|
WO2021188414A1
(en)
|
2020-03-16 |
2021-09-23 |
Enanta Pharmaceuticals, Inc. |
Functionalized heterocyclic compounds as antiviral agents
|
AU2021237718B2
(en)
|
2020-03-20 |
2023-09-21 |
Gilead Sciences, Inc. |
Prodrugs of 4'-C-substituted-2-halo-2'-deoxyadenosine nucleosides and methods of making and using the same
|
PE20230779A1
(es)
|
2020-08-07 |
2023-05-09 |
Gilead Sciences Inc |
Profarmacos de analogos de nucleotidos de fosfonamida y su uso farmaceutico
|
TWI815194B
(zh)
|
2020-10-22 |
2023-09-11 |
美商基利科學股份有限公司 |
介白素2-Fc融合蛋白及使用方法
|
WO2022241134A1
(en)
|
2021-05-13 |
2022-11-17 |
Gilead Sciences, Inc. |
COMBINATION OF A TLR8 MODULATING COMPOUND AND ANTI-HBV siRNA THERAPEUTICS
|
AU2022299051A1
(en)
|
2021-06-23 |
2023-12-07 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
WO2022271677A1
(en)
|
2021-06-23 |
2022-12-29 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
CA3222439A1
(en)
|
2021-06-23 |
2022-12-29 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
EP4359413A1
(en)
|
2021-06-23 |
2024-05-01 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|